ETV5 and hepatocellular carcinoma: TRPV4 modifies cytoskeleton-related protein to promote the migration and invasion of HCC cells, and alters sc polarity via activating Ca2+-dependent AMPK/MLC/ERM pathway, which increases the adhesion of metastatic HCC cells to blood vessels.